Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Insulet Corporation (PODD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Insulet's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
167.25 -0.02    -0.01%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
167.21
-0.04
-0.02%
19:43:15 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 543,381
  • Bid/Ask: 167.20 / 169.00
  • Day's Range: 165.85 - 169.34
Insulet 167.25 -0.02 -0.01%

Insulet Corporation Company Profile

 
Get an in-depth profile of Insulet Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

3000

Equity Type

ORD

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company’s Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Contact Information

Address 100 Nagog Park
Acton, 01720
United States
Phone 978 600 7000
Fax -

Top Executives

Name Age Since Title
Timothy J. Scannell 56 2014 Independent Chairman
Margaret Lawlor - - Member of Educator Advisory Board
Howard Wolpert - - Member of Scientific Advisory Board
John B. Buse - - Member of Scientific Advisory Board
Anne Daly - - Member of Educator Advisory Board
Michael R. Minogue 55 2017 Independent Director
Mary Halvorson - - Member of Educator Advisory Board
Barbara J. Anderson - - Member of Educator Advisory Board
Robert S. Sherwin - - Chairman of Scientific Advisory Board
James R. Hollingshead 59 2019 President, CEO & Director
Luciana Borio 50 2021 Independent Director
Camille Izlar - - Member of Educator Advisory Board
Steven V. Edelman 66 - Member of Scientific Advisory Board
Jessica Hopfield 57 2015 Director
Wayne Alix-Ian Frederick 50 2020 Independent Director
Corinne H. Nevinny 62 2019 Independent Director
Elizabeth H. Weatherman 62 2022 Independent Director
Shacey Petrovic 51 2016 Director & Advisor
Timothy C. Stonesifer 57 2024 Independent Director
Flavia H. Pease 51 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PODD Comments

Write your thoughts about Insulet Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
air man
air man Jul 16, 2021 8:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AIRI and PODD is good stock
VALUE TIMER
VALUE TIMER Nov 19, 2020 8:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you know 'EOFLOW(294090)' in KOSDAQ(Republic of Korea)?Search this stock. It is similar with Insulet.
duroy paris
duroyparis May 20, 2020 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
250+ by the end of the quarter
Michelle Saint
Michelle Saint Dec 10, 2019 2:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news on PODD?
travert xavier
travert xavier Nov 27, 2019 11:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
725..
travert xavier
travert xavier Nov 08, 2019 3:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
597 PE.. Interesting view on american obesity and illness expectation
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email